Clinical Trials Directory

Trials / Completed

CompletedNCT02433015

Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Laureate Institute for Brain Research, Inc. · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to examine the cognitive, immunological, and neurophysiological effects of transitioning from tobacco cigarettes to electronic cigarettes. The central hypothesis of this study is that this transition will be accompanied by a decrease in peripheral inflammation, which will lead to significant changes in the neurocircuitry underlying interoception and appetite.

Detailed description

Participants who are current cigarette smokers will be randomly assigned to either the experimental or control groups. Following a baseline psychiatric assessment session, subjects will return to the study center for two to three additional follow-up visits. During the second visit, all subjects will undergo a functional magnetic resonance imaging (fMRI) scanning session, during which they will perform a series of functional neuroimaging tasks designed to examine the neural substrates involved in visceral interoception and eating behavior. Prior to the start of the scan session, blood samples will be collected from each subject, for the measurement of bio-markers related to nicotine use and peripheral inflammation. After the end of the second visit, subjects within the experimental group will be asked to switch from combustible to electronic cigarettes. Subjects within the control group will continue to smoke combustible cigarettes as previously. During the third visit, which will follow two to eight weeks after the second visit, all subjects will provide a second blood sample and complete a second fMRI scan session. Both groups of participants will complete the same fMRI tasks as they did during the second visit.

Conditions

Interventions

TypeNameDescription
OTHERElectronic CigaretteeGo-type electronic cigarette with a supply of 18mg/ml nicotine solution
OTHERTobacco CigaretteSmoke own brand of cigarette as previously

Timeline

Start date
2015-01-01
Primary completion
2016-09-24
Completion
2016-09-24
First posted
2015-05-04
Last updated
2017-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02433015. Inclusion in this directory is not an endorsement.